Skip to content

Ethiopia to provide ARVs to 50,000 by July

Treatment started early in HIV infection effective and well tolerated for up to five years

Genotypic resistance testing on a failing regimen is possible below 1000 copies/ml

Five cancers seen in vicriviroc study `not causally related`, study continues

Best results in HIV-positive children if treatment started before five months of age

Merck announces 20% cut in efavirenz price for low and middle-income countries

CROI: Early vs delayed Trizivir in TB/HIV coinfected - no difference in rate of IRIS

CROI: More data on role of antiretrovirals, interventions, HCV, in cardiovascular disease risk

Restoration of CD4 T-cells limited in children starting HIV treatment at low CD4 percentages